A Study of Evorpacept (ALX148) in Patients With Advanced Solid Tumors and Lymphoma (ASPEN-01)
ALX Oncology Inc.
ALX Oncology Inc.
Progen Pharmaceuticals
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
NYU Langone Health
National Institutes of Health Clinical Center (CC)